Troy Harasym
11Patents
10h-index
18Co-inventors
69Inventor score
Filing activity: May 14, 1998 → Jul 27, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6858225B2 | Lipid-encapsulated polyanionic nucleic acid | Emerging Cross-Sectional Technologies | 185 | Expired |
| US6287591A | Charged therapeutic agents encapsulated in lipid particles containing four lipid components | Emerging Cross-Sectional Technologies | 125 | Expired |
| US6835395B1 | Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles | Emerging Cross-Sectional Technologies | 110 | Expired |
| US7341738B2 | Lipid-encapsulated polyanionic nucleic acid | Emerging Cross-Sectional Technologies | 87 | Expired |
| US8021686B2 | Lipid-encapsulated polyanionic nucleic acid | Emerging Cross-Sectional Technologies | 58 | Active |
| US8022279B2 | Liposomal formulations of anthracycline agents and cytidine analogs | Emerging Cross-Sectional Technologies | 48 | Active |
| US9271931B2 | Compositions for delivery of drug combinations | Human Necessities | 38 | Active |
| US8431806B2 | Liposomal formulations of anthracycline agents and cytidine analogs | Emerging Cross-Sectional Technologies | 38 | Active |
| US10058507B2 | Compositions for delivery of drug combinations | Human Necessities | 37 | Active |
| US7850990B2 | Compositions for delivery of drug combinations | Human Necessities | 37 | Active |
| US10722464B2 | Compositions for delivery of drug combinations | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.